title: The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.
abstract: Allogeneic hematopoietic SCT with reduced-intensity conditioning (RIC-HSCT) is increasingly adopted for the treatment of older adults with AML. Our goal was to verify for the first time, if center experience influences outcome of RIC-HSCT. Results of 1413 transplantations from HLA-matched related or unrelated donors for adult patients with AML in first CR were analyzed according to the level of center activity. Transplants were performed in 203 European centers between 2001 and 2007. The 2-year probability of leukemia-free survival (LFS) after RIC-HSCT performed in centers with the lowest activity (< or =15 procedures/7 years) was 43±3% compared with 55±2% in the remainder (P<0.001). The incidence of non-relapse mortality (NRM) was 24±3% and 15±1% (P=0.004), whilst relapse rate was 33±3% and 31±1% (P=0.33), respectively. In a multivariate model, adjusted for other prognostic factors, low RIC-HSCT activity was associated with decreased chance of LFS (hazard ratio (HR)=0.64; P<0.001) and increased risk of NRM (HR=1.47, P=0.04) and relapse (HR=1.41, P=0.01). Center experience is a very important predictor of outcome and should be considered in future analyses evaluating the results of RIC-HSCT. The reasons why centers with low RIC-HSCT activity have worse outcomes should be further investigated.
authors: Department of Bone Marrow Transplantation, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Gliwice, Poland. sgiebel@io.gliwice.pl
authors: S
authors: S
authors: Giebel
authors: M
authors: M
authors: Labopin
authors: M
authors: M
authors: Mohty
authors: G J
authors: GJ
authors: Mufti
authors: D
authors: D
authors: Niederwieser
authors: J J
authors: JJ
authors: Cornelissen
authors: J J W M
authors: JJ
authors: Janssen
authors: N
authors: N
authors: Milpied
authors: L
authors: L
authors: Vindelov
authors: E
authors: E
authors: Petersen
authors: R
authors: R
authors: Arnold
authors: A
authors: A
authors: Bacigalupo
authors: D
authors: D
authors: Blaise
authors: C
authors: C
authors: Craddock
authors: A
authors: A
authors: Nagler
authors: F
authors: F
authors: Frassoni
authors: M
authors: M
authors: Sadus-Wojciechowska
authors: V
authors: V
authors: Rocha
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D008875:Middle Aged; D012189:Retrospective Studies; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D055815:Young Adult